Omzet 2024 * | 54,97 mld. 50,78 mld. | Omzet 2025 * | 58 mld. 53,59 mld. | Marktkapitalisatie | 285 mld. 264 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,74 mld. 7,15 mld. | Nettowinst (verlies) 2025 * | 10,64 mld. 9,83 mld. | EV/omzet 2024 * | 6,17 x |
Nettoschuld 2024 * | 53,62 mld. 49,54 mld. | Nettoschuld 2025 * | 47,29 mld. 43,69 mld. | EV/omzet 2025 * | 5,73 x |
K/w-verhouding 2024 * |
31,4
x | K/w-verhouding 2025 * |
24,1
x | Werknemers | - |
Dividendrendement 2024 * |
3,82% | Dividendrendement 2025 * |
4,02% | Vrij verhandelbaar | 96,37% |
Recentste transcriptie over AbbVie
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01-01-13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01-01-13 |
Robert Michael
PSD | President | 53 | 01-01-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01-01-13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01-01-13 |
Director/Board Member | 70 | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,06% | 688 mld. | |
+30,35% | 588 mld. | |
-3,42% | 364 mld. | |
+18,02% | 326 mld. | |
+15,53% | 239 mld. | |
+10,16% | 210 mld. | |
-8,14% | 200 mld. | |
+8,12% | 167 mld. | |
-1,42% | 161 mld. |